Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of Deferred ChargesAmortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in IntangiblesChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares IssuedShares RepurchasedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Amphastar Pharmaceuticals (AMPH) Cash from Financing Activities (2016 - 2026)

Amphastar Pharmaceuticals has reported Cash from Financing Activities over the past 13 years, most recently at -$18.4 million for Q4 2025.

  • For Q4 2025, Cash from Financing Activities rose 45.71% year-over-year to -$18.4 million; the TTM value through Dec 2025 reached -$67.4 million, up 16.71%, while the annual FY2025 figure was -$67.4 million, 16.71% up from the prior year.
  • Cash from Financing Activities for Q4 2025 was -$18.4 million at Amphastar Pharmaceuticals, down from -$4.3 million in the prior quarter.
  • Over five years, Cash from Financing Activities peaked at $428.1 million in Q2 2023 and troughed at -$47.1 million in Q4 2023.
  • A 5-year average of $12.1 million and a median of -$13.6 million in 2023 define the central range for Cash from Financing Activities.
  • Biggest five-year swings in Cash from Financing Activities: plummeted 3730.84% in 2021 and later skyrocketed 43169.52% in 2023.
  • Year by year, Cash from Financing Activities stood at -$8.7 million in 2021, then plummeted by 85.86% to -$16.2 million in 2022, then plummeted by 191.32% to -$47.1 million in 2023, then increased by 28.12% to -$33.8 million in 2024, then soared by 45.71% to -$18.4 million in 2025.
  • Business Quant data shows Cash from Financing Activities for AMPH at -$18.4 million in Q4 2025, -$4.3 million in Q3 2025, and -$30.2 million in Q2 2025.